Form 4 holding
Group Chief Medical Officer
Telix Pharmaceuticals Ltd
- Security class
- Ordinary Shares
- Shares / value
- 373,133
- Estimated value
- $2,794,766
- Report date
- 18 Mar 2026
- Price
- $7.49
- Ownership
- Direct
David Norman Cade - Group Chief Medical Officer at Telix Pharmaceuticals Ltd
Issuer-level insider activity
- Role
- Group Chief Medical Officer
- Issuer ticker
- TLX on Nasdaq, TLPPF on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David Norman Cade since 17 Aug 2025
Reported holdings for David Norman Cade in Telix Pharmaceuticals Ltd
Transaction history for David Norman Cade in Telix Pharmaceuticals Ltd
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.